Blog

glove/hand concept of FDA approval with bottles

FDA Approval of Cresnessity Signals Breakthrough for Rare Endocrine Disorder

For over 70 years, patients with classic congenital adrenal hyperplasia (CAH) have had limited treatment options—options that often come with debilitating side effects. However, a new chapter begins with the recent FDA approval of Neurocrine Biosciences’ Crenessity, the first non-steroidal treatment for CAH. This decision heralds a groundbreaking shift in the management of this rare […]

FDA Approval of Cresnessity Signals Breakthrough for Rare Endocrine Disorder Read More »

Digital health network communication

Harnessing AI and Predictive Analytics: The Future of Personalized Patient Support

Healthcare is entering an era of profound transformation, and personalized medicine stands at its forefront. This shift has not only reshaped clinical approaches but has also expanded into patient support systems. For market access and patient services teams, predictive analytics and artificial intelligence (AI) offer opportunities to revolutionize how we assist patients. By leveraging powerful

Harnessing AI and Predictive Analytics: The Future of Personalized Patient Support Read More »

Female doctor and patient in clinic, closeup.

Novocure’s Tumor Treating Fields Device Breaks New Ground in Pancreatic Cancer Treatment

Pancreatic cancer, one of the most challenging cancers to treat, accounts for an alarming number of deaths each year, with a five-year survival rate lingering at just 13%. However, recent advancements in cancer treatment have provided a glimmer of hope. Novocure, a global oncology company, has announced groundbreaking results for its Tumor Treating Fields (TTFields)

Novocure’s Tumor Treating Fields Device Breaks New Ground in Pancreatic Cancer Treatment Read More »

Doctor and patient discussing something in clinic

Revolutionizing Patient Services in Cell and Gene Therapies

In the rapidly evolving world of healthcare, cell and gene therapies stand out as groundbreaking advancements that hold the potential to radically change patient outcomes. For pharma manufacturers and patient services teams, navigating these complex therapies requires unprecedented strategies and innovations. This blog delves into the intricacies of the patient journey, the role of patient

Revolutionizing Patient Services in Cell and Gene Therapies Read More »

Doctor using digital tablet with medical icons on background

Unveiling Muse: The AI Revolution in Drug Development and Patient Recruitment

In a groundbreaking move that is set to revolutionize the pharmaceutical industry, Formation Bio, Sanofi, and OpenAI have joined forces to introduce Muse, an AI tool poised to transform patient recruitment in drug development. This collaboration unites the expertise of three industry giants, each bringing unique strengths to the table, all aimed at accelerating the

Unveiling Muse: The AI Revolution in Drug Development and Patient Recruitment Read More »

Measuring Success in Rare Disease Patient Support Programs with Effective KPIs

Tackling the intricacies of rare disease treatments demands comprehensive patient support programs. These initiatives are vital for individuals who encounter unique obstacles when accessing treatments and managing their conditions. To ensure these programs’ effectiveness, it is crucial to assess their impact accurately, which is where Key Performance Indicators (KPIs) become essential. This guide delves into

Measuring Success in Rare Disease Patient Support Programs with Effective KPIs Read More »

CAR-T Cell Therapy

AvenCell’s $112M Boost to Propel Its CAR-T Therapy for Acute Myeloid Leukemia

In the intricate world of cancer treatment, AvenCell Therapeutics has made waves with its recent achievement. The company successfully raised $112 million in a Series B funding round to further develop its promising CAR-T cell therapies targeting acute myeloid leukemia (AML). This funding is a significant stride toward tackling what many in the industry call “the

AvenCell’s $112M Boost to Propel Its CAR-T Therapy for Acute Myeloid Leukemia Read More »

AI in Biopharma

AI in Biopharma: Uncovering the Latest Game-Changers in Drug Discovery

The biopharmaceutical industry stands on the brink of a technological revolution. Artificial Intelligence (AI) is poised to transform how drugs are discovered, developed, and delivered. This transformation is not just a future vision; it’s happening now, with significant developments emerging almost weekly. In this blog post, we’ll take a deep dive into the recent advancements

AI in Biopharma: Uncovering the Latest Game-Changers in Drug Discovery Read More »

Buy and Bill

Exploring the Buy-and-Bill Model: Strategies and Trends in Pharmaceutical Distribution

Navigating the complex world of pharmaceutical distribution can be daunting for market access teams and pharmaceutical professionals. At the heart of this complexity lies the buy-and-bill model, a predominant method for distributing provider-administered drugs. This blog post aims to clarify how the buy-and-bill model works, explore its benefits and challenges, and provide insights into emerging

Exploring the Buy-and-Bill Model: Strategies and Trends in Pharmaceutical Distribution Read More »

Biopharma Fed Rate Cut

The Federal Reserve’s Impact on Biopharma: Opportunities and Challenges Amidst Interest Rate Cuts

The Federal Reserve’s recent decision to cut interest rates has sent ripples through various industries, but what does it mean for biopharma? Last week, the Fed announced a rate cut by half a percentage point, marking the first reduction since March 2020. This move has been met with a mixture of optimism and caution within

The Federal Reserve’s Impact on Biopharma: Opportunities and Challenges Amidst Interest Rate Cuts Read More »